Neurodevelopmental outcome of hypoglycaemia in healthy, large for gestational age, term newborns

Area of Science:

• Neonatal Medicine
• Developmental Pediatrics
• Pediatric Neurology

Background:

• Neonatal hypoglycemia is common in large for gestational age (LGA) infants.
• The long-term neurodevelopmental effects of transient neonatal hypoglycemia are not fully understood.
• This study focuses on healthy term LGA infants born to non-diabetic mothers.

Purpose of the Study:

• To assess the neurodevelopmental outcomes at 4 years of age in healthy term LGA infants experiencing transient neonatal hypoglycemia.
• To determine if neonatal hypoglycemia impacts cognitive and behavioral development in early childhood.

Main Methods:

• Screening for hypoglycemia was conducted in the first hours after birth, with continued monitoring and treatment for severe or symptomatic cases.
• Neurodevelopmental assessment at 4 years included the Denver Developmental Scale and Child Behaviour Check List.
• Comparison between normoglycemic and hypoglycemic groups, including analysis of subgroups based on treatment.

Main Results:

• No significant differences in overall neurodevelopmental scores (Denver Developmental Scale, Child Behaviour Check List) were found between infants with and without neonatal hypoglycemia.
• A statistically significant difference was observed in one IQ subscale (reasoning) in favor of the normoglycemic group, but this finding was not consistently observed with alternative hypoglycemia definitions.
• No differences in test scores were noted between hypoglycemic infants who received intravenous glucose treatment and those who did not.

Conclusions:

• Transient mild hypoglycemia in healthy term LGA newborns does not appear to be detrimental to psychomotor development at 4 years of age.
• The observed minor difference in reasoning skills requires further investigation and was not consistently found across different analytical approaches.